ArticleBMC cancer2025

Efficacy and safety of combining tislelizumab with capecitabine compared to capecitabine alone in the adjuvant treatment of biliary tract cancers: rationale and protocol design for a randomized clinical trial.

Xubiao Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.